Craig Rosenfeld

During 20 years of practice as a board-certified hematologist and oncologist, devised, conducted, and led numerous clinical research protocols from preclinical research to FDA approval, resulting in close to 100 publications in peer-reviewed journals and book publications. Craig Rosenfeld was a Chief Scientific Officer and Senior Vice President of SuperGen, Inc. (2002-2004), responsible for directing the pivotal clinical trials leading to FDA approval of Dacogen and Director of Bone Marrow Transplant programs at the Western Pennsylvania Cancer Institute (1990-1994) and Medical City Dallas Hospital (1994-2001).